Mark Williams has over 20 years of experience evaluating and providing financial solutions to healthcare companies spanning the breadth of the Healthcare Industry, with specific engagements in Biotechnology, Health Care Information Technology, Equipment and Devices, Providers and Services, and Pharmaceuticals. Engagements include Public as well as Private Equity backed transactions including equity investments, senior and subordinated debt capital provisions, and derivative hedging solutions. Before joining Emerging Growth as a Senior Equity Research Analyst, Mark has held positions at top financial institutions with responsibilities that include the launch of multiple Healthcare Verticals focused on providing Investment and Banking solutions to clients of all sizes engaged in the healthcare industry. Mark attended the Raymond A. Mason Graduate School of Business earning a Master’s in Business Administration. He is a current member of the CFA Institute® and holder of the Chartered Financial Analyst® designation.